Skip to main content
Research project

Optimizing MATrix as remission induction treatment for newly diagnosed primary CNS Lymphoma – a randomized phase III trial (OPTIMATE trial)

Research groups:
Lead researcher:
Other researchers:
Research funder:
Cancer Research UK
Status:
Active
Back to top